Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications.

Francesco Branda, Chiara Romano, Massimo Ciccozzi, Marta Giovanetti, Fabio Scarpa, Alessandra Ciccozzi, Antonello Maruotti
Author Information
  1. Francesco Branda: Unit of Medical Statistics and Molecular Epidemiology, Universit�� Campus Bio-Medico di Roma, 00128 Rome, Italy. ORCID
  2. Chiara Romano: Unit of Medical Statistics and Molecular Epidemiology, Universit�� Campus Bio-Medico di Roma, 00128 Rome, Italy.
  3. Massimo Ciccozzi: Unit of Medical Statistics and Molecular Epidemiology, Universit�� Campus Bio-Medico di Roma, 00128 Rome, Italy. ORCID
  4. Marta Giovanetti: Sciences and Technologies for Sustainable Development and One Health, Universit�� Campus Bio-Medico di Roma, 00128 Roma, Italy. ORCID
  5. Fabio Scarpa: Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43b, 07100 Sassari, Italy. ORCID
  6. Alessandra Ciccozzi: Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43b, 07100 Sassari, Italy.
  7. Antonello Maruotti: Department GEPLI, Libera Universit�� Maria Ss Assunta, 00193 Rome, Italy. ORCID

Abstract

Mpox, caused by viruses of the genus Orthopoxvirus, is an emerging threat to human and animal health. With increasing urbanization and more frequent interaction between humans and wild animals, the risk of Mpox transmission to humans has increased significantly. This review aims to examine in depth the epidemiology, pathogenesis, and diagnosis of Mpox, with a special focus on recent discoveries and advances in understanding the disease. Molecular mechanisms involved in viral replication will be examined, as well as risk factors associated with interspecific transmission and spread of the disease in human populations. Currently available diagnostic methods will also be discussed, with a critical analysis of their limitations and possible future directions for improving the accuracy and timeliness of diagnosis. Finally, this review will explore the public health implications associated with Mpox, emphasizing the importance of epidemiological surveillance, vaccination, and emergency preparedness to prevent and manage possible outbreaks. Understanding the epidemiology and control strategies for Mpox is critical to protecting the health of human and animal communities and mitigating the risk of interspecific transmission and spread of the disease.

Keywords

References

  1. Virol Sin. 2022 Aug;37(4):477-482 [PMID: 35820590]
  2. Vector Borne Zoonotic Dis. 2012 May;12(5):400-9 [PMID: 22217169]
  3. J Med Virol. 2023 Jan;95(1):e28306 [PMID: 36372558]
  4. New Microbiol. 2005 Jan;28(1):1-12 [PMID: 15782621]
  5. J Med Virol. 2023 Jan;95(1):e28270 [PMID: 36319946]
  6. J Virol Methods. 2010 Oct;169(1):223-7 [PMID: 20643162]
  7. Lancet. 2012 Dec 1;380(9857):1936-45 [PMID: 23200502]
  8. Signal Transduct Target Ther. 2023 Sep 15;8(1):350 [PMID: 37709783]
  9. Virol J. 2023 Sep 18;20(1):214 [PMID: 37723564]
  10. Lancet. 2022 Nov 5;400(10363):1618 [PMID: 36252575]
  11. Immunol Rev. 2008 Oct;225:96-113 [PMID: 18837778]
  12. Emerg Infect Dis. 2017 Dec;23(13): [PMID: 29155676]
  13. Int J Forecast. 2022 Apr-Jun;38(2):423-438 [PMID: 32863495]
  14. Vaccines (Basel). 2023 Jan 21;11(2): [PMID: 36851118]
  15. J Virol. 2015 Feb;89(3):1889-99 [PMID: 25428875]
  16. J Clin Epidemiol. 2021 Aug;136:96-132 [PMID: 33781862]
  17. Socioecon Plann Sci. 2023 Jun;87:101516 [PMID: 36713286]
  18. Environmetrics. 2022 Dec;33(8):e2768 [PMID: 36712697]
  19. Nat Commun. 2024 Mar 11;15(1):2199 [PMID: 38467622]
  20. J Med Virol. 2023 Jan;95(1):e28159 [PMID: 36124421]
  21. Front Microbiol. 2023 Feb 01;14:1106247 [PMID: 36819041]
  22. F1000Res. 2018 Jun 11;7: [PMID: 29946427]
  23. Nat Rev Immunol. 2012 Jan 20;12(2):136-48 [PMID: 22266691]
  24. Disaster Med Public Health Prep. 2015 Aug;9(4):447-58 [PMID: 26186579]
  25. PLoS Negl Trop Dis. 2011 Oct;5(10):e1356 [PMID: 22028942]
  26. Front Cell Infect Microbiol. 2023 Jul 18;13:1196699 [PMID: 37533932]
  27. Viruses. 2023 Nov 23;15(12): [PMID: 38140542]
  28. J Clin Med. 2022 Oct 28;11(21): [PMID: 36362616]
  29. Virol J. 2010 May 28;7:110 [PMID: 20509894]
  30. J Clin Virol Plus. 2022 Nov;2(4):100114 [PMID: 36248765]
  31. Semin Pediatr Infect Dis. 2003 Jul;14(3):189-95 [PMID: 12913830]
  32. Pathogens. 2023 Sep 11;12(9): [PMID: 37764961]
  33. Emerg Infect Dis. 2019 May;25(5):980-983 [PMID: 30848724]
  34. Viruses. 2024 Jan 04;16(1): [PMID: 38257783]
  35. Elife. 2023 Apr 21;12: [PMID: 37083521]
  36. mSphere. 2021 Feb 3;6(1): [PMID: 33536322]
  37. Cancer Immunol Res. 2013 Sep;1(3):145-9 [PMID: 24777676]
  38. Infect Drug Resist. 2023 Dec 21;16:7759-7766 [PMID: 38146310]
  39. Nat Commun. 2023 Aug 25;14(1):5186 [PMID: 37626059]
  40. Front Immunol. 2021 Oct 27;12:741837 [PMID: 34777354]
  41. Epidemiol Infect. 2023 May 23;151:e121 [PMID: 37218612]
  42. Cell. 2016 Oct 20;167(3):684-694.e9 [PMID: 27768891]
  43. J Infect Public Health. 2023 Apr;16(4):531-541 [PMID: 36801633]
  44. Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7374-7379 [PMID: 29941567]
  45. Am J Trop Med Hyg. 2015 Aug;93(2):410-5 [PMID: 26013374]
  46. N Engl J Med. 2022 Nov 10;387(19):1783-1793 [PMID: 36286263]
  47. N Engl J Med. 2004 Jan 22;350(4):342-50 [PMID: 14736926]
  48. Lancet Glob Health. 2023 Jul;11(7):e1012-e1023 [PMID: 37349031]
  49. Afr J Lab Med. 2020 Aug 26;9(2):1019 [PMID: 32934913]
  50. NPJ Vaccines. 2023 Nov 20;8(1):178 [PMID: 37985781]
  51. Infect Prev Pract. 2023 Sep 12;5(4):100308 [PMID: 38107242]
  52. MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):547-552 [PMID: 37200231]

Word Cloud

Created with Highcharts 10.0.0MpoxhumanhealthrisktransmissionepidemiologydiseasewillOrthopoxvirusanimalhumansreviewdiagnosisassociatedinterspecificspreadcriticalpossiblesurveillancecausedvirusesgenusemergingthreatincreasingurbanizationfrequentinteractionwildanimalsincreasedsignificantlyaimsexaminedepthpathogenesisspecialfocusrecentdiscoveriesadvancesunderstandingMolecularmechanismsinvolvedviralreplicationexaminedwellfactorspopulationsCurrentlyavailablediagnosticmethodsalsodiscussedanalysislimitationsfuturedirectionsimprovingaccuracytimelinessFinallyexplorepublicimplicationsemphasizingimportanceepidemiologicalvaccinationemergencypreparednesspreventmanageoutbreaksUnderstandingcontrolstrategiesprotectingcommunitiesmitigatingMpox:OverviewPathogenesisDiagnosisPublicHealthImplications

Similar Articles

Cited By